290 related articles for article (PubMed ID: 31485847)
1. NK and NKT-like cells in granulomatous and fibrotic lung diseases.
Bergantini L; Cameli P; d'Alessandro M; Vagaggini C; Refini RM; Landi C; Pieroni MG; Spalletti M; Sestini P; Bargagli E
Clin Exp Med; 2019 Nov; 19(4):487-494. PubMed ID: 31485847
[TBL] [Abstract][Full Text] [Related]
2. Innate immunity alterations in idiopathic interstitial pneumonias and rheumatoid arthritis-associated interstitial lung diseases.
Papanikolaou IC; Boki KA; Giamarellos-Bourboulis EJ; Kotsaki A; Kagouridis K; Karagiannidis N; Polychronopoulos VS
Immunol Lett; 2015 Feb; 163(2):179-86. PubMed ID: 25540922
[TBL] [Abstract][Full Text] [Related]
3. Bronchoalveolar lavage fluid and blood natural killer and natural killer T-like cells in cryptogenic organizing pneumonia.
Papakosta D; Manika K; Gounari E; Kyriazis G; Kontakiotis T; Spyropoulos G; Kontakioti E; Zarogoulidis K
Respirology; 2014 Jul; 19(5):748-54. PubMed ID: 24889556
[TBL] [Abstract][Full Text] [Related]
4. Prognostic role of NK cell percentages in bronchoalveolar lavage from patients with different fibrotic interstitial lung diseases.
Bergantini L; d'Alessandro M; Cameli P; Otranto A; Finco T; Curatola G; Sestini P; Bargagli E
Clin Immunol; 2021 Sep; 230():108827. PubMed ID: 34428741
[TBL] [Abstract][Full Text] [Related]
5. CCL18 in serum, BAL fluid and alveolar macrophage culture supernatant in interstitial lung diseases.
Cai M; Bonella F; He X; Sixt SU; Sarria R; Guzman J; Costabel U
Respir Med; 2013 Sep; 107(9):1444-52. PubMed ID: 23831213
[TBL] [Abstract][Full Text] [Related]
6. NK and NKT cells in the diagnosis of diffuse lung diseases presenting with a lymphocytic alveolitis.
Sokhatska O; Padrão E; Sousa-Pinto B; Beltrão M; Mota PC; Melo N; Delgado L; Morais A
BMC Pulm Med; 2019 Feb; 19(1):39. PubMed ID: 30760244
[TBL] [Abstract][Full Text] [Related]
7. Association between Pepsin in Bronchoalveolar Lavage Fluid and Prognosis of Chronic Fibrosing Interstitial Lung Disease.
Kim Y; Lee YJ; Cho YJ; Yoon HI; Lee JH; Lee CT; Park JS
Tohoku J Exp Med; 2018 Nov; 246(3):147-153. PubMed ID: 30405002
[TBL] [Abstract][Full Text] [Related]
8. BAL biomarkers' panel for differential diagnosis of interstitial lung diseases.
d'Alessandro M; Carleo A; Cameli P; Bergantini L; Perrone A; Vietri L; Lanzarone N; Vagaggini C; Sestini P; Bargagli E
Clin Exp Med; 2020 May; 20(2):207-216. PubMed ID: 31970550
[TBL] [Abstract][Full Text] [Related]
9. Integrated approach to bronchoalveolar lavage cytology to distinguish interstitial lung diseases.
Bergantini L; d'Alessandro M; Cameli P; Perrone A; Cekorja B; Boncompagni B; Mazzei MA; Sestini P; Bargagli E
Eur J Intern Med; 2021 Jul; 89():76-80. PubMed ID: 33931268
[TBL] [Abstract][Full Text] [Related]
10. Bronchoalveolar Lavage Lymphocytes in the Diagnosis of Hypersensitivity Pneumonitis among Patients with Interstitial Lung Disease.
Patolia S; Tamae Kakazu M; Chami HA; Chua A; Diaz-Mendoza J; Duggal A; Jenkins AR; Knight SL; Raghu G; Wilson KC
Ann Am Thorac Soc; 2020 Nov; 17(11):1455-1467. PubMed ID: 32757946
[No Abstract] [Full Text] [Related]
11. Bronchoalveolar lavage fluid eosinophils are correlated to natural killer cells in eosinophilic pneumonias.
Papakosta D; Manika K; Kyriazis G; Kontakiotis T; Gioulekas D; Polyzoni T; Bouros D; Patakas D
Respiration; 2009; 78(2):177-84. PubMed ID: 19246876
[TBL] [Abstract][Full Text] [Related]
12. Expansion of pulmonary CD8+CD56+ natural killer T-cells in hypersensitivity pneumonitis.
Korosec P; Osolnik K; Kern I; Silar M; Mohorcic K; Kosnik M
Chest; 2007 Oct; 132(4):1291-7. PubMed ID: 17646229
[TBL] [Abstract][Full Text] [Related]
13. Characterization of natural killer and T cells in bronchoalveolar lavage and peripheral blood of sarcoidosis patients.
Bergantini L; d'Alessandro M; Del Zotto G; Marcenaro E; Bargagli E
Front Immunol; 2022; 13():1080556. PubMed ID: 36685602
[TBL] [Abstract][Full Text] [Related]
14. Bronchoalveolar Lavage Fluid Characteristics of Patients With Sarcoidosis and Nonsarcoidosis Interstitial Lung Diseases: Ten-Year Experience of a Single Center in Turkey.
Tanriverdi H; Erboy F; Altinsoy B; Uygur F; Arasli M; Ozel Tekin I; Tor MM; Atalay F
Iran Red Crescent Med J; 2015 Oct; 17(10):e31103. PubMed ID: 26566455
[TBL] [Abstract][Full Text] [Related]
15. BAL cytokine profile in different interstitial lung diseases: a focus on systemic sclerosis.
Meloni F; Caporali R; Marone Bianco A; Paschetto E; Morosini M; Fietta AM; Patrizio V; Bobbio-Pallavicini F; Pozzi E; Montecucco C
Sarcoidosis Vasc Diffuse Lung Dis; 2004 Jun; 21(2):111-8. PubMed ID: 15281432
[TBL] [Abstract][Full Text] [Related]
16. IL-9 and IL-9 receptor expression in lymphocytes from bronchoalveolar lavage fluid of patients with interstitial lung disease.
Jehn LB; Costabel U; Boerner E; Wessendorf TE; Theegarten D; Taube C; Bonella F
Immunobiology; 2022 Sep; 227(5):152258. PubMed ID: 35998415
[TBL] [Abstract][Full Text] [Related]
17. Bronchoalveolar lavage fluid cellular characteristics, functional parameters and cytokine and chemokine levels in interstitial lung diseases.
Vasakova M; Sterclova M; Kolesar L; Slavcev A; Pohunek P; Sulc J; Skibova J; Striz I
Scand J Immunol; 2009 Mar; 69(3):268-74. PubMed ID: 19281539
[TBL] [Abstract][Full Text] [Related]
18. Enhanced expression of Fas Ligand (FasL) in the lower airways of patients with fibrotic interstitial lung diseases (ILDs).
Kopiński P; Balicka-Ślusarczyk B; Dyczek A; Szpechciński A; Przybylski G; Jarzemska A; Wandtke T; Jankowski M; Iwaniec T; Chorostowska-Wynimko J
Folia Histochem Cytobiol; 2011; 49(4):636-45. PubMed ID: 22252758
[TBL] [Abstract][Full Text] [Related]
19. Cytotoxic lymphocytes in COPD airways: increased NK cells associated with disease, iNKT and NKT-like cells with current smoking.
Eriksson Ström J; Pourazar J; Linder R; Blomberg A; Lindberg A; Bucht A; Behndig AF
Respir Res; 2018 Dec; 19(1):244. PubMed ID: 30526599
[TBL] [Abstract][Full Text] [Related]
20. Local and Systemic Concentrations of Pattern Recognition Receptors of the Lectin Pathway of Complement in a Cohort of Patients With Interstitial Lung Diseases.
Vogt S; Trendelenburg M; Tamm M; Stolz D; Hostettler KE; Osthoff M
Front Immunol; 2020; 11():562564. PubMed ID: 33101280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
